Cormorant Asset Management LP 13D and 13G filings for Rapport Therapeutics, Inc. Common Stock:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 3:11 pm Purchase |
2024-09-30 | 13G | Rapport Therapeutics, Inc. Common Stock RAPP |
Cormorant Asset Management LP | 2,940,921 8.040% |
638 (+0.02%) |
Filing |
| 2024-06-20 4:01 pm Purchase |
2024-06-10 | 13G | Rapport Therapeutics, Inc. Common Stock RAPP |
Cormorant Asset Management LP | 2,940,283 8.040% |
2,940,283 (New Position) |
Filing |